Approximately 14 percent of the world's population suffer from dry eye disease (DED) but treatments are limited because it's difficult to model the complex human eye for drug development. Now though, University of Pennsylvania bioengineers developed an "eye-on-a-chip" complete with a motorized blinking eyelid. The hope is that the artificial eye will lead to a deeper understanding of dry eye disease, enable drug screening, and even become a testbed for contact lens technology and eye surgery. Their technology also received the 2018 Lush Prize awarded for innovations that could help eliminate animal testing for shampoos and other beauty product. From Eurekalert:
In this study, (Dan) Huh and (Jeongyun) Seo focused on engineering an eye model that could imitate a healthy eye and an eye with DED, allowing them to test an experimental drug without risk of human harm.
To construct their eye-on-a-chip, Huh's team starts with a porous scaffold engineered with 3D printing, about the size of a dime and the shape of a contact lens, on which they grow human eye cells. The cells of the cornea grow on the inner circle of scaffolding, dyed yellow, and the cells of the conjunctiva, the specialized tissue covering the white part of human eyes, grow on the surrounding red circle. A slab of gelatin acts as the eyelid, mechanically sliding over the eye at the same rate as human blinking. Fed by a tear duct, dyed blue, the eyelid spreads artificial tear secretions over the eye to form what is called a tear film.
"From an engineering standpoint, we found it interesting to think about the possibility of mimicking the dynamic environment of a blinking human eye. Blinking serves to spread tears and generate a thin film that keeps the ocular surface hydrated. It also helps form a smooth refractive surface for light transmission. This was a key feature of the ocular surface that we wanted to recapitulate in our device," says Huh.
My family stopped wiping down all our groceries to "disinfect" them a couple months ago, mostly because of hygiene exhaustion. Then in May, the Center for Disease Control and Prevention clarified its own Web page about how COVID-19 spreads to state that "based on data from lab studies on COVID-19 and what we know about […]
Every year, hundreds of thousands of horseshoe crabs, a threatened species, are "milked" for up to 30% of their blood that's used to test new medical drugs, including possible COVID-19 vaccines, for bacterial contamination. The animals are eventually released but, surprise, a large percentage of them die. Revive & Restore, the wildlife conservation organization most […]
The US government announced funding clinical trials on three COVID-19 vaccine candidates. According to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, we're still on track for a vaccine at scale by the end of this year or early 2021. From CNN: Phase 3 trials, which typically involve tens of thousands […]
Everybody's got a story. Unfortunately, not everybody has the tools to tell that story the right way. That's especially true for someone looking to produce their first screenplay. Just as with any type of writing, penning a script for the screen has a set of rules all its own. Understanding that structure, as well as […]
Even as the world takes tentative steps toward reopening against the ebbs and flows of COVID-19, movie theaters remain in a netherworld limbo. High-profile film releases continue shuffling as theater chains, studios and filmgoers grapple with the fact that an enclosed theater may not be a safe place to be for some time to come. […]
The year 2020 has basically kicked down that door and dragged us all into the Zoom age, whether we like it or not. And now that we're basically inviting our boss, co-workers and other business associates into our homes via video, we've unwittingly stumbled into all kinds of new potential for embarrassment. Like when you're […]